Structure-activity relationship of flavonoid bifunctional inhibitors against Zika virus infection

被引:40
|
作者
Zou, Min [1 ]
Liu, Hongmiao [1 ]
Li, Jingyan [1 ]
Yao, Xingang [1 ]
Chen, Yi [1 ]
Ke, Changwen [2 ]
Liu, Shuwen [1 ]
机构
[1] Southern Med Univ, Sch Pharmaceut Sci, Guangdong Prov Key Lab New Drug Screening, Guangzhou Key Lab Drug Res Emerging Virus Prevent, 1838 Northern Guangzhou Rd, Guangzhou 510515, Peoples R China
[2] Guangdong Prov Ctr Dis Control & Prevent, Guangzhou, Guangdong, Peoples R China
关键词
Zika virus; Flavonoids; Antiviral; Entry inhibitors; Protease; NS2B-NS3; PROTEASE; FLAVIVIRUS; COMPOUND; SURAMIN; CELLS; ENTRY; REPLICATION; EGCG;
D O I
10.1016/j.bcp.2020.113962
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Zika virus (ZIKV) infection is a global public health problem due to its rapid spread and the possibility of causing microcephaly. Currently, no specific antivirals against ZIKV are available for treatment. In the present study, several flavonoids (galangin, kaempferide, quercetin, myricetin and EGCG) were found to reduce ZIKV induced plaques and viral RNA copies with negligible cytotoxic effects on host cells. In addition, inhibition of ZIKV propagation by flavonoids showed structure-activity relationship. Our results demonstrate flavonoids as inhibitors of ZIKV entry and NS2B-NS3 protease. Hence, these flavonoids could be used as potential bifunctional drugs for treating ZIKV infections.
引用
收藏
页数:9
相关论文
共 50 条
  • [31] Humoral Immune Responses Against Zika Virus Infection and the Importance of Preexisting Flavivirus Immunity
    Priyamvada, Lalita
    Suthar, Mehul S.
    Ahmed, Rafi
    Wrammert, Jens
    JOURNAL OF INFECTIOUS DISEASES, 2017, 216 : S906 - S911
  • [32] Design, synthesis and exploring the quantitative structure-activity relationship of some antioxidant flavonoid analogues
    Das, Sreeparna
    Mitra, Indrani
    Batuta, Shaikh
    Alam, Md. Niharul
    Roy, Kunal
    Begum, Naznin Ara
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2014, 24 (21) : 5050 - 5054
  • [33] Antiviral activity of theaflavins against Zika virus in vivo and in vitro
    Deng, Xiuwen
    Lv, Chaoxiang
    Wang, Tiecheng
    Guo, Jin
    Luo, Rongbo
    Qi, Jing
    Sima, Mingwei
    Yue, Donghui
    Gao, Yuwei
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2024, 30 (06) : 571 - 578
  • [34] Characterization and structure-activity relationship study of iminodipyridinopyrimidines as novel hepatitis C virus inhibitor
    Park, Dong-Sik
    Jo, Eunji
    Choi, Jihyun
    Lee, MyungEun
    Kim, Soohyun
    Kim, Hee-Young
    Nam, Jiyon
    Ahn, Sujin
    Hwang, Jong Yeon
    Windisch, Marc Peter
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2017, 140 : 65 - 73
  • [35] Synthesis and structure-activity relationship of nuciferine derivatives as potential acetylcholinesterase inhibitors
    Yang, Zhongduo
    Song, Zhuwen
    Xue, Weiwei
    Sheng, Jie
    Shu, Zongmei
    Shi, Yin
    Liang, Jibei
    Yao, Xiaojun
    MEDICINAL CHEMISTRY RESEARCH, 2014, 23 (06) : 3178 - 3186
  • [36] Anti-influenza A virus activity of flavonoids in vitro: a structure-activity relationship
    Morimoto, Ryosuke
    Hanada, Akari
    Matsubara, Chiaki
    Horio, Yuka
    Sumitani, Hidenobu
    Ogata, Tokutaro
    Isegawa, Yuji
    JOURNAL OF NATURAL MEDICINES, 2023, 77 (01) : 219 - 227
  • [37] Design, synthesis and discovery of andrographolide derivatives against Zika virus infection
    Li, Feng
    Lee, Emily M.
    Sun, Xia
    Wang, Decai
    Tang, Hengli
    Zhou, Guo-Chun
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2020, 187
  • [38] Zika virus infection confers protection against West Nile virus challenge in mice
    Vazquez-Calvo, Angela
    Blazquez, Ana-Belen
    Escribano-Romero, Estela
    Merino-Ramos, Teresa
    Saiz, Juan-Carlos
    Martin-Acebesw, Miguel A.
    de Oya, Nereida Jimenez
    EMERGING MICROBES & INFECTIONS, 2017, 6 : 1 - 6
  • [39] The novel therapeutic target and inhibitory effects of PF-429242 against Zika virus infection
    Raini, Sandra Kendra
    Takamatsu, Yuki
    Dumre, Shyam Prakash
    Urata, Shuzo
    Mizukami, Shusaku
    Moi, Meng Ling
    Hayasaka, Daisuke
    Inoue, Shingo
    Morita, Kouichi
    Tun, Mya Myat Ngwe
    ANTIVIRAL RESEARCH, 2021, 192
  • [40] Structure-activity relationships for the selectivity of hepatitis C virus NS3 protease inhibitors
    Poliakov, A
    Johansson, A
    Åkerblom, E
    Oscarsson, K
    Samuelsson, B
    Hallberg, A
    Danielson, UH
    BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 2004, 1672 (01): : 51 - 59